Report an error

Spotted something inaccurate in “Oral GLP-1 Drug Elecoglipron Achieves 10.5% Weight Loss in Phase 2 Trial”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.